ArticleTherapeutic advances in gastroenterology2024
Long-term outcomes and predictors of vedolizumab persistence in ulcerative colitis.
Beatriz Gros et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it